CELSION
Celsion is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative cancer treatments, including immunotherapies and DNA-based therapies; and a platform for the development of nucleic acid vaccines currently focused on SARS-CoV2. The companyโs product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer. ThermoDoxยฎ, a proprietary heat-activated liposomal encapsulation of doxorubicin, is under investigator-sponsored development for several cancer indications. Celsion also has two feasibility stage platform technologies for the development of novel nucleic acid-based immunotherapies and other anti-cancer DNA or RNA therapies.
CELSION
Industry:
Biotechnology Health Care Therapeutics
Founded:
1982-01-01
Address:
Lawrenceville, New Jersey, United States
Country:
United States
Website Url:
http://www.celsion.com
Total Employee:
11+
Status:
Active
Contact:
609-896-9100
Email Addresses:
[email protected]
Total Funding:
78.79 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
![]()
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapyโbased treatments for cardiovascular disease.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Vigeo Therapeutics
Vigeo Therapeutics is a biopharmaceutical company developing novel therapeutic agents intended to treat advanced malignant tumors.
Current Advisors List
![]()
![]()
Current Employees Featured
![]()
![]()
![]()

Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2014-06-10 | EGEN | EGEN acquired by Celsion | N/A |
Investors List
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Celsion
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-19 | Celsion Appoints Dr. Corinne Le Goff as President and Chief Executive Officer |
Official Site Inspections
http://www.celsion.com Semrush global rank: 3.67 M Semrush visits lastest month: 3.84 K
- Host name: 208.209.208.35.bc.googleusercontent.com
- IP address: 35.208.209.208
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
